ADVANCED TECHNOLOGY LABORATORIES INC
S-8, 1997-06-25
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: LEHMAN BROTHERS HOLDINGS INC, 424B2, 1997-06-25
Next: IAI INVESTMENT FUNDS III INC, N-30D, 1997-06-25



                                   
   As filed with the Securities and Exchange Commission on June 24,1997

                                             Registration No. 333-
                                   
                  SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549
                        ______________________
                                   
                               FORM S-8
                        REGISTRATION STATEMENT
                                 UNDER
                      THE SECURITIES ACT OF 1933
                        ______________________
                                   
                ADVANCED TECHNOLOGY LABORATORIES, INC.
        (Exact name of Registrant as specified in its charter)
                                   
            Washington                         91-1353386
 (State or other jurisdiction of    (I.R.S. Employer Identification
  incorporation or organization)                  No.)
                                   
                     22100 Bothell Everett Highway
                             P.O. Box 3003
                        Bothell, WA 98041-3003
     (Address of principal executive offices, including zip code)
                                   
                               
         AMENDED 1992 NONOFFICER EMPLOYEE STOCK OPTION PLAN
                                                     
                     EMPLOYEE STOCK PURCHASE PLAN
                        (Full title of the plan)
                                   
                                   
                         W. BRINTON YORKS, Jr.
             Vice President, General Counsel and Secretary
                ADVANCED TECHNOLOGY LABORATORIES, INC.
                     22100 Bothell-Everett Highway
                             P.O. Box 3003
                        Bothell, WA 98041-3003
                            (425) 487-7000
     (Name, address and telephone number, including area code, of
                          agent for service)
                                   
                          __________________
                                   
                                   
                    CALCULATION OF REGISTRATION FEE

                          
                              Proposed     Proposed         
Title of                      Maximum      Maximum      
Securities       Number to    Offering     Aggregate    Amount of
to Be            be           Price Per    Offering     Registration
Registered       Registered   Share(1)     Price(1)     Fee
- ----------       ----------   --------     ----------   ------------         
Common Stock,  
par value 
$.01 per Share   350,000(2)   $41.375      $14,481,250  $4,388.26

(1)  Estimated solely for the purpose of calculating the registration
     fee pursuant to Rule 457(h).  The price per share is estimated to
     be $41.375 based on the average of the high and low prices for
     the Common Stock in the over-the-counter market on June 23, 1997
     as reported on the Nasdaq National Market.



(2)  Of this number, 50,000 are being registered for issuance pursuant
     to the Amended 1992 Nonofficer Employee Stock Option Plan and
     300,000 are being registered for issuance pursuant to the
     Employee Stock Purchase Plan.  In addition to this number of
     shares, an indeterminate number of additional shares which may be
     necessary to adjust the number of shares reserved for issuance
     pursuant to such plans as the result of any future stock split,
     stock dividend or similar adjustment of the outstanding Common
     Stock of the Registrant.
                                   
                             Page 1 of 29
                      Exhibit Index is on page 6
                              
<PAGE>

            REGISTRATION OF ADDITIONAL SECURITIES
     
     Pursuant to General Instruction E, this registration
statement on Form S-8 is filed by Advanced Technology
Laboratories, Inc. (the "Registrant") to register additional
securities under the Plans described in Registration
Statement Nos. 33-54757 (including post-effective Amendment
No.1 thereto (the "Post-Effective Amendment")), 33-59914, 33-
61807 and 333-08881, to be issued pursuant to an amendment
and adoption of the Plans by the Registrant's Board of
Directors on February 26, 1997 and May 7, 1997, and by the
Registrant's Shareholders on May 7, 1997.  Portions of
Registration Statement 33-54757, 33-59914, 33-61807 and 333-
08881 and the Post-Effective Amendment are incorporated
herein by reference.
                              
                           PART II
                              
       INFORMATION REQUIRED IN REGISTRATION STATEMENT
                              
                              

Item 3.  INCORPORATION OF CERTAIN DOCUMENTS BY
         REFERENCE

The following documents are hereby incorporated by reference
in this Registration Statement:

          (a)  The Registrant's Annual Report on Form 10-K
for the year ended December 31, 1996 filed on March 28,
1997;
          
          (b)  All other reports filed by the Registrant
pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), since
the end of the fiscal year covered by the Annual Report
referred to in (a) above;
          
          (c)  The description of the Registrant's Common
Stock contained in the Current Report on Form 8-K filed on
January 11, 1996; and

          (d)  The description of the Registrant's Common
Stock contained in the Registration Statement on Form 10
(Registration No. 0-15160) filed with the Commission on
November 12, 1986 under Section 12(g) of the Exchange Act,
and any amendment or report filed for the purpose of
updating such description.
          
     All documents filed by the Registrant pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act
after the date hereof, and prior to the filing of a post-
effective amendment which indicates that the securities
offered hereby have been sold or which deregisters the
securities covered hereby then remaining unsold, shall also
be deemed to be incorporated by reference into this
Registration Statement and to be a part hereof commencing on
the respective dates on which such documents are filed.

Item 4.        Not Applicable

Item 5.        Not Applicable

Item 6.        INDEMNIFICATION OF DIRECTORS AND OFFICERS.

    Incorporated herein by reference to the Post-Effective
Amendment on Form S-8, filed with the Commission on August
11, 1995 under Registration Statement No. 33-54757.

Item 7.        Not Applicable

                              2

<PAGE>

Item 8.  EXHIBITS

 Exhibit                        
 Number                   Description
 -------     ------------------------------------------ 
   5.1       Opinion of Bogle & Gates P.L.L.C.
          
  10.1       Amended 1992 Nonofficer Employee Stock
             Option Plan
          
  10.2       Employee Stock Purchase Plan
          
  23.1       Consent of KPMG Peat Marwick LLP
            
  23.2       Consent of Bogle & Gates P.L.L.C. (included
             in opinion filed as Exhibit 5.1)
          
  24.1       Power of Attorney (see signature page)


Item 9.  UNDERTAKINGS

A.    The undersigned Registrant hereby undertakes:

(1)  To file, during any period in which offers or sales are being 
made, a post-effective amendment to this Registration Statement:

          (i)  To include any prospectus required by Section
10(a)(3) of the Securities Act of 1933, as amended (the
"Securities Act");

          (ii) To reflect in the prospectus any facts or
events arising after the effective date of this Registration
Statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent
a fundamental change in the information set forth in this
Registration Statement.  Notwithstanding the foregoing, any
increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or
high and of the estimated maximum offering  range may be
reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if in the aggregate, the
changes in volume and price represent no more than a 20
percent change in the maximum aggregate offering price set
forth in the "Calculation of Registration Fee" table in the
effective registration statement;

          (iii)     To include any material information with
respect to the plan of distribution not previously disclosed
in this Registration Statement or any material change to
such information in this Registration Statement;

provided, however, that paragraphs (A)(1)(i) and (A)(1)(ii)
- --------  -------
above do not apply if the registration statement is on Form
S-8 or Form S-3, and the information required to be included
in a post-effective amendment by those paragraphs is
contained in periodic reports filed with or furnished to the
Commission by the Registrant pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by
reference in this Registration Statement.

     Undertakings pursuant to Regulation S-K Rule 512(b) and
(h) are incorporated by reference to Registration Statement
Nos. 33-54757, 33-59914, 33-61807 and 333-08881 and the Post-
Effective Amendment.

                              3
<PAGE>

    The Registrant.  Pursuant to the requirements of the
    --------------
Securities Act of 1933, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this
Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of
Bothell, State of Washington, on this 24th day of
June, 1997.

                              ADVANCED TECHNOLOGY
                              LABORATORIES INC.


                              By /s/ Dennis C. Fill
                                 -------------------------
                                 Dennis C. Fill, Chairman
                                 and Chief Executive Officer



    The Plan.  Solely with respect to the Registrant's
    --------
Employee Stock Purchase Plan and pursuant to the
requirements of the Securities Act of 1933, the trustees (or
other persons who administer the employee benefit plan) have
duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the
City of Bothell, State of Washington, on this 24th day of
June, 1997.


                              EMPLOYEE STOCK
                              PURCHASE PLAN


                              By /s/ Harvey N. Gillis
                                ------------------------
                                Harvey N. Gillis, Senior
                                Vice President
                                and Chief Financial Officer


                      POWER OF ATTORNEY

    Each person whose signature appears below constitutes
and appoints Dennis C. Fill and W. Brinton Yorks, Jr., and
each of them, his true and lawful attorneys-in-fact and
agents, with full power of substitution, for him and in his
name, place and stead, in any and all capacities, to sign
any amendments to the Registration Statements, and to file
the same, with exhibits thereto and other documents in
connection therewith, with the Securities and Exchange
Commission, hereby ratifying and confirming all that said
attorneys-in-fact, or their substitute or substitutes, may
do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of
1933, this Registration Statement has been signed by the
following persons in the capacities and on the date
indicated on June 24, 1997.



           Signature            Title
                                
      /s/ Dennis C. Fill        Chairman of the Board, Chief
     ----------------------     Executive Officer
        Dennis C. Fill          
                                
      /s/ Harvey N. Gillis      Senior Vice President, Chief
     ----------------------     Financial Officer (Principal
        Harvey N. Gillis        Financial Officer)
                                

                                4
<PAGE>
          
                                
      /s/ Kirby L. Cramer        Director
     ----------------------
        Kirby L. Cramer
               
                                
     /s/ Harvey Feigenbaum      Director
     ----------------------
     Harvey Feigenbaum, M.D.
               
                                
     /s/ Eugene A. Larson       Director
     -------------------- 
       Eugene A. Larson
               
                                
       /s/ Ernest Mario         Director
     -------------------- 
     Ernest Mario, Ph.D.
               
                                
      /s/ John R. Miller        Director
     --------------------
        John R. Miller
               
                                
    /s/ Phillip M. Nudelman     Director
    -----------------------
   Phillip M. Nudelman, Ph.D.
               
                                
        /s/ Harry Woolf         Director
      --------------------
      Harry Woolf, Ph.D.
               
                                
    /s/ Richard S. Totorica     Vice President and Corporate
    -----------------------     Controller (Principal Accounting
      Richard S. Totorica       Officer)

                              5
<PAGE>
                              
                              
                      INDEX TO EXHIBITS
     

                                                      Sequentially
 Exhibit                                                Numbered
 Number                   Description                     Page
 -------     --------------------------------------     --------          
                                                            
   5.1       Opinion of Bogle & Gates P.L.L.C.             7
                                                            
  10.1       Amended 1992 Nonofficer Employee Stock      8 - 22
             Option Plan
                                                            
  10.2       Employee Stock Purchase Plan               23 - 28
                                                            
  23.1       Consent of KPMG Peat Marwick LLP             29
                                                            
  23.2       Consent of Bogle & Gates P.L.L.C.(included        
             in opinion filed as Exhibit 5.1)
                                                            
  24.1       Power of Attorney (see signature page)            
                              
                              6
     
<PAGE>
     



     
     
     
     
     
     
     
Bogle & Gates P.L.L.C. Letterhead                           Exhibit 5.1

                                                            June 24, 1997


Advanced Technology Laboratories, Inc.
22100 Bothell Everett Highway
Bothell, WA 98041-3003

Gentlemen and Ladies:

    We are acting as counsel to Advanced TechnologyLaboratories, Inc., a 
Washington corporation (the "Company"), in connection with the filing of 
a registration statement on Form S-8 (the "Registration Statement") under
the Securities Act of 1933, as amended, with the Securities and Exchange 
Commission, relating to the proposed sale by the Company of an aggregate 
of 350,000 shares of its common stock, par value $0.01 per share (the 
"Common Stock"), issuable pursuant to the Company's Amended 1992 Nonofficer
Employee Stock Option Plan, and the Employee Stock Purchase
Plan.

    In connection with the foregoing, we are of the opinion that the 
Common Stock will, when sold, be legally issued, fully paid and nonassessable.

    We hereby authorize and consent to the use of this opinion as Exhibit 
5.1 to the Registration Statement.

                                        Very truly yours,


                                        Bogle & Gates P.L.L.C.
                                        
                                      
                              




                                        Exhibit 10.1

                                        February 26, 1997




           ADVANCED TECHNOLOGY LABORATORIES, INC.
                              
         1992 Nonofficer Employee Stock Option Plan


1.  Definitions

        The following terms have the corresponding meanings
for purposes of the Plan:

     "Change of Control" means

     (a)  a "Board Change."  For purposes of the Plan, a
Board Change shall have occurred if a majority of the seats
(other than vacant seats) on the Corporation's Board of
Directors (the "Board") were to be occupied by individuals
who were neither (i) nominated by a majority of the
Incumbent Directors nor (ii) appointed by directors so
nominated.  An "Incumbent Director" is a member of the Board
who has been either (i) nominated by a majority of the
directors of the Corporation then in office or (ii)
appointed by directors so nominated, but excluding, for this
purpose, any such individual whose initial assumption of
office occurs as a result of either an actual or threatened
election contest (as such terms are used in Rule 14a-11 of
Regulation 14A promulgated under the Securities Exchange Act
of 1934, as amended (the "Exchange Act")) or other actual or
threatened solicitation of proxies or consents by or on
behalf of a Person other than the Board; or

     (b)  the acquisition by any individual, entity or group
(within the meaning of Section 13(d)(3) or 14(d)(2) of the
Exchange Act) (a "Person") of "Beneficial Ownership" (within
the meaning of Rule 13d-3 promulgated under the Exchange
Act) of (i) 20% or more of either (A) the then outstanding
shares of common stock (the "Outstanding Corporation Common
Stock") or (B) the combined voting power of the then
outstanding voting securities of the Corporation entitled to
vote generally in the election of directors (the
"Outstanding Corporation Voting Securities"), in the case of
either (A) or (B) of this clause (i), which acquisition is
not approved in advance by a majority of the Incumbent
Directors or (ii) 33% or more of either (A) the Outstanding
Corporation Common Stock or (B) the Outstanding Corporation
Voting Securities, in the case of either (A) or (B) of this

                           1
<PAGE>

clause (ii), which acquisition is approved in advance by a
majority of the Incumbent Directors; provided, however, that
the following acquisitions shall not constitute a Change of
Control: (x) any acquisition by the Corporation, (y) any
acquisition by any employee benefit plan (or related trust)
sponsored or maintained by the Corporation or any
corporation controlled by the Corporation, or (z) any
acquisition by any corporation pursuant to a reorganization,
merger or consolidation, if, following such reorganization,
merger or consolidation, the conditions described in clauses
(i), (ii) and (iii) of the following subsection (c) are
satisfied; or

     (c)  approval by the stockholders of the Corporation of
a reorganization, merger or consolidation, in each case,
unless, immediately following such reorganization, merger or
consolidation, (i) more than 60% of, respectively, the then
outstanding shares of common stock of the corporation
resulting from such reorganization, merger or consolidation
and the combined voting power of the then outstanding voting
securities of such corporation entitled to vote generally in
the election of directors is then beneficially owned,
directly or indirectly, by all or substantially all of the
individuals and entities who were the beneficial owners,
respectively, of the Outstanding Corporation Common Stock
and Outstanding Corporation Voting Securities immediately
prior to such reorganization, merger or consolidation in
substantially the same proportions as their ownership,
immediately prior to such reorganization, merger or
consolidation, of the Outstanding Corporation Common Stock
and Outstanding Corporation Voting Securities, as the case
may be, (ii) no Person (excluding the Corporation, any
employee benefit plan (or related trust) of the Corporation
or such corporation resulting from such reorganization,
merger or consolidation and any Person beneficially owning,
immediately prior to such reorganization, merger or
consolidation, directly or indirectly, 33% or more of the
Outstanding Corporation Common Stock or Outstanding
Corporation Voting Securities, as the case may be)
beneficially owns, directly or indirectly, 33% or more of,
respectively, the then outstanding shares of common stock of
the corporation resulting from such reorganization, merger
or consolidation or the combined voting power of the then
outstanding voting securities of such corporation entitled
to vote generally in the election of directors, and (iii)
at least a majority of the members of the board of directors
of the corporation resulting from such reorganization,
merger or consolidation were Incumbent Directors at the time
of the execution of the initial agreement providing for such
reorganization, merger or consolidation; or

                          2
<PAGE>

     (d)  approval by the stockholders of the Corporation of
(i) a complete liquidation or dissolution of the Corporation
or (ii) the sale or other disposition of all or
substantially all of the assets of the Corporation, other
than to a corporation, with respect to which immediately
following such sale or other disposition, (A) more than 60%
of, respectively, the then outstanding shares of common
stock of such corporation and the combined voting power of
the then outstanding voting securities of such corporation
entitled to vote generally in the election of directors is
then beneficially owned, directly or indirectly, by all or
substantially all of the individuals and entities who were
the beneficial owners, respectively, of the Outstanding
Corporation Common Stock and Outstanding Corporation Voting
Securities immediately prior to such sale or other
disposition in substantially the same proportion as their
ownership, immediately prior to such sale or other
disposition, of the Outstanding Corporation Common Stock and
Outstanding Corporation Voting Securities, as the case may
be, (B) no Person (excluding the Corporation and any
employee benefit plan (or related trust) of the Corporation
or such corporation and any Person beneficially owning,
immediately prior to such sale or other disposition,
directly or indirectly, 33% or more of the Outstanding
Corporation Common Stock or Outstanding Corporation Voting
Securities, as the case may be) beneficially owns, directly
or indirectly, 33% or more of, respectively, the then
outstanding shares of common stock of such corporation and
the combined voting power of the then outstanding voting
securities of such corporation entitled to vote generally in
the election of directors, and (C) at least a majority of
the members of the board of directors of such corporation
were approved by a majority of the Incumbent Directors at
the time of the execution of the initial agreement or action
of the Board providing for such sale or other disposition of
assets of the Corporation.

     "Committee" means the Committee provided for in Section
4, which shall administer the Plan.

     "Common Stock" means common stock, par value $0.01 per
share, of the Corporation.

     "Corporation" means Advanced Technology Laboratories,
Inc., a Delaware corporation.

     "Designated Beneficiary" means any person designated in
writing by a Participant as a legal recipient of payments
due under an award in the event of the Participant's death,

                          3
<PAGE>

or in the absence of such designation, the Participant's
estate.  Such designation must be on file with the
Corporation in order to be effective but, unless the
Participant has made an irrevocable designation, may be
changed from time to time by the Participant.

     "Fair Market Value" of the Common Stock as of any
trading day means the average (rounded to the next highest
cent in the case of fractions of a cent) of the high and low
sales prices of the Common Stock as reported on such trading
day by the NASDAQ National Market System.  If no sales price
is reported for the Common Stock on such trading day, then
"Fair Market Value" shall mean the highest bid price
reported for the Common Stock on such trading day by the
National Quotation Bureau Incorporated or any similar
nationally recognized organization.  The Committee, in its
sole discretion, shall make all determinations required by
this definition.

     "Participant" means an employee who has received an
award under the Plan.

     "Plan" means this Advanced Technology Laboratories,
Inc. 1992 Nonofficer Employee Stock Option Plan.

     "Retirement" means the termination of the services of a
Participant because of early or normal retirement as defined
in the Westmark Retirement Plan.

     "Withholding Tax" means any tax, including any federal,
state or local income tax or payroll tax, required by any
governmental entity to be withheld or otherwise deducted and
paid with respect to the transfer of shares of Common Stock
as a result of the exercise of an option.

2.  Stock Subject to the Plan

     There are reserved for issuance upon the exercise of
options under the Plan 370,000 shares of Common Stock.  Such
shares may be authorized and unissued shares of Common Stock
or previously outstanding shares of Common Stock then held
in the Corporation's treasury.  If any option granted under
the Plan shall expire or terminate for any reason
(including, without limitation, by reason of its surrender,
pursuant to the provisions of Section 6(f) or the third
paragraph of Section 6(b) or otherwise, or cancellation, in
whole or in part, pursuant to the provisions of Section 6(c)
or otherwise, or the substitution in place thereof of a new
option) without having been exercised in full, the shares

                            4
<PAGE>

subject thereto shall again be available for the purposes of
issuance under the Plan.

3.  Administration

     (a)  The Plan shall be administered by the Committee.
Subject to the express provisions of the Plan, the Committee
shall have plenary authority, in its discretion, to
determine the individuals to whom, and the time or times at
which options shall be granted and the number of shares to
be covered by each such grant.  In making such
determinations, the Committee may take into account the
nature of the services rendered by the respective
Participants, their present and potential contributions to
the Corporation's success and such other factors as the
Committee in its discretion may deem relevant.  Subject to
the express provisions of the Plan, the Committee shall have
plenary authority to interpret the Plan, to prescribe, amend
and rescind rules and regulations relating to it, to
determine the terms and provisions of option agreements
(which need not be identical) and to make all other
determinations necessary or advisable for the administration
of the Plan.  The Committee's determinations of the matters
referred to in this Section 3 shall be conclusive.  It is
the intention of the Corporation that the Plan and the
administration hereof comply in all respects with Section
16(b) of the Exchange Act, and the rules and regulations
promulgated thereunder, and if any Plan provision is later
found not to be in compliance with Section 16(b), the
provision shall be deemed null and void, and in all events
the Plan shall be construed in favor of its meeting the
requirements of Rule 16b-3.

     (b)  The Committee may in its discretion delegate to a
committee appointed by the Board consisting of one or more
officers of the Corporation (the "Grant Committee") the
authority to grant, pursuant to this Plan, options for a
total number of shares of Common Stock determined by the
Committee, and under terms, conditions and criteria which
are approved by the Committee.  Such authorization may
include the ability to determine the Participants to whom,
the number of shares in respect of which, and the time or
times at which, such options shall be granted.  In the event
the Committee shall grant such authority to the Grant
Committee, the Grant Committee shall  report to the
Committee in writing, at times determined by the Committee,
(i) the names of Participants who have received any such
grants, (ii) the number of shares covered by each option so
granted, (iii) the date upon which each such option was
granted and (iv) such other information as the committee may

                             5
<PAGE>

request.  Any action of the Grant Committee pursuant to
authority granted by the Committee under this Section 3(b)
in accordance with the Committee resolution granting such
authority shall be deemed to be the action of the Committee.

4.  The Committee

     (a)  The Board shall designate a Committee of members
of the Board which shall meet the requirements of Section
16(b) of the Exchange Act.  Currently, the Committee shall
consist solely of two or more members of the Board who are
disinterested.  If at any time an insufficient number of
disinterested directors is available to serve on such
Committee, interested directors may serve on the Committee;
however, during such time, no options shall be granted under
the Plan to any person if the granting of such options would
not meet the requirements of Section 16(b) of the Exchange
Act.

     (b)  For purposes of this Section 4, a "disinterested
director" is a person who meets the definition of
"disinterested person" as set forth in the rules and
regulations promulgated under Section 16(b) of the Exchange
Act.  Currently, a disinterested director is a member of the
Board who is not (and, during the 12-month period preceding
his appointment as a member of the Committee has not been)
granted or awarded stock, stock appreciation rights or other
equity securities of the Corporation or any affiliated
corporation pursuant to the Plan or any other plan of the
Corporation or any affiliated corporation except for formula
plans (as such term is defined in Rule 16b-3(c)(2)(ii)
issued under the Exchange Act) or ongoing securities
acquisition plans (as described in Rule 16b-3(d)(2)(i)
issued under the Exchange Act).  The Committee shall be
appointed by the Board, which may from time to time appoint
members of the Committee in substitution for members
previously appointed and may fill vacancies, however caused,
in the Committee.  The Committee shall select one of its
members as its Chairman and shall hold its meetings at such
times and places as it may determine.  A majority of its
members shall constitute a quorum.  All determinations of
the Committee shall be made by not less than a majority of
its members.  Any decision or determination reduced to
writing and signed by all the members shall be fully as
effective as if it had been made by a majority vote at a
meeting duly called and held.  The Committee may appoint a
secretary, shall keep minutes of its meetings and shall make
such rules and regulations for the conduct of its business
as it shall deem advisable.

                           6
<PAGE>

5.  Eligibility

        The Committee may grant options only to employees of
the Corporation and of its present and future subsidiary
corporations ("subsidiaries") who, at the time of the grant,
are not officers or directors (within the meaning of Section
16 of the Exchange Act and the rules and regulations
promulgated thereunder) of the Corporation or any of its
present and future subsidiary corporations.  Any person
eligible under the Plan may receive one or more grants of
options as the Committee shall from time to time determine,
and such determinations may be different as to different
Participants.

6.  Option Grants

     (a)  The Committee is authorized under the Plan, in its
discretion, to issue only options which do not qualify as
"incentive stock options" as defined in Section 422 of the
United States Internal Revenue Code of 1986, as amended
("Nonqualified Stock Options") and the options shall be
designated as Nonqualified Stock Options in the applicable
option agreement.  The purchase price of the Common Stock
under each option granted under the Plan shall be determined
by the Committee but shall be not less than the average Fair
Market Value of the Common Stock over any continuous period
of trading days beginning and ending no more than 30
business days before or after the date such option is
granted.

     (b)  The Committee shall be authorized in its
discretion to prescribe in the option grant the
installments, if any, in which an option granted under the
Plan shall become exercisable, provided that no option shall
be exercisable prior to the first anniversary of the date of
grant thereof except as provided in Section 6(c), (d), (g),
and (h) or except as the Committee otherwise determines.  In
no case may an option be exercised as to less than 100
shares at any one time (or the remaining shares covered by
the option if less than 100) during the term of the option.
The Committee shall also be authorized to establish the
manner of the exercise of an option.  The term of each
option shall be not more than 10 years from the date of
grant thereof.  In general, upon exercise, the option price
is to be paid in full in cash; however, the Committee can
determine at any time prior to exercise that additional
forms of payment will be permitted.  To the extent permitted
by the Committee and applicable laws and regulations
(including, but not limited to, federal tax and securities
laws and regulations and state corporate law), an option may

                              7
<PAGE>

be exercised (i) in Common Stock owned by the option holder
having a Fair Market Value on the date of exercise equal to
the aggregate option price, or in a combination of cash and
stock; provided, however, that payment in stock shall not be
made unless such stock shall have been owned by the option
holder for a period of at least three months prior thereto;
or (ii) by delivery of a properly executed exercise notice,
together with irrevocable instructions to a broker
designated by the Corporation, all in accordance with the
regulations of the Federal Reserve Board, to deliver
promptly to the Corporation the amount of sale or loan
proceeds to pay the exercise price and any Withholding Tax
obligations that may arise in connection with the exercise.

     In lieu of requiring an option holder to pay cash or
stock and to receive in turn certificates for shares of
Common Stock upon the exercise of an option, if the option
agreement so provides, the Committee may elect to require
the option holder to surrender the option to the Corporation
for cancellation as to all or any portion of the number of
shares covered by the intended exercise and receive in
exchange for such surrender a payment, at the election of
the Committee, in cash, in shares of Common Stock or in a
combination of cash and shares of Common Stock, equivalent
to the appreciated value of the shares covered by the option
surrendered for cancellation.  Such appreciated value shall
be the difference between the option price of such shares
(as adjusted pursuant to Section 15) and the Fair Market
Value of such shares, which shall for this purpose be
determined by the Committee taking into consideration all
relevant factors, but which shall not be less than the Fair
Market Value of such shares on the date on which the option
holder's notice of exercise is received by the Corporation.
Upon delivery to the Corporation of a notice of exercise of
option, the Committee may avail itself of its right to
require the option holder to surrender the option to the
Corporation for cancellation as to shares covered by such
intended exercise.  The Committee's right of election shall
expire, if not exercised, at the close of business on the
fifth business day following the delivery to the Corporation
of such notice.  Should the Committee not exercise such
right of election, the delivery of the aforesaid notice of
exercise shall constitute an exercise by the option holder
of the option to the extent therein set forth, and payment
for the shares covered by such exercise shall become due
immediately.

     (c)  In the event that a Participant's services for the
Corporation or one of its subsidiaries shall cease and the
termination of such individual's service is for cause, the

                            8
<PAGE>

option shall automatically terminate upon first notification
to the option holder of such termination of services, unless
the Committee determines otherwise, and such option shall
automatically terminate upon the date of such termination of
services for all shares which were not purchasable upon such
date.  For purposes of this Section 6(c), "cause" is defined
as a determination by the Committee that the option holder
(i) has committed a felony, (ii) has engaged in an act or
acts of deliberate and intentional dishonesty resulting or
intended to result directly or indirectly in improper
material gain to or personal enrichment of the individual at
the Corporation's expense, or (iii) has willfully disobeyed
the Corporation's appropriate rules, instructions or orders,
and such willful disobedience has continued for a period of
10 days following notice thereof from the Corporation.

     In the event of the termination of the services of the
holder of an option because of Retirement or disability, he
or she may (unless such option shall have been previously
terminated pursuant to the provisions of the preceding
paragraph or unless otherwise provided in the option grant)
exercise such option at any time prior to the expiration of
the option, (i) in the event of disability or normal
Retirement, to the extent of the number of shares covered by
such option, whether or not such shares had become
purchasable by him or her at the date of the termination of
his or her services and (ii) in the event of early
Retirement, to the extent of the number of shares covered by
such option at such time or times as such option becomes
purchasable by him or her in accordance with its terms.

     In the event of the death of an individual to whom an
option has been granted under the Plan, while he or she is
performing services for the Corporation or a subsidiary, the
option theretofore granted to him or her (unless the option
shall have been previously terminated pursuant to the
provisions of this Section 6(c) or unless otherwise provided
in the option grant) may, subject to the limitations
described in Section 6(g), be exercised by his or her
Designated Beneficiary, by his or her legatee or legatees of
the option under his last will, or by his or her personal
representatives or distributees, at any time within a period
of one year after his or her death, but not after the
expiration of the option, to the extent of the remaining
shares covered by the option whether or not such shares had
become purchasable by such an individual at the date of
death.  In the event of the death of an individual (i)
during the one-year period following termination of his or
her services or (ii) following termination of his or her
services by reason of Retirement or disability, then the

                       9

option (if not previously terminated pursuant to the
provisions of this Section 6(c)) may be exercised during the
remainder of such one-year period or during the remaining
term of the option, respectively, by his or her Designated
Beneficiary, by his or her legatee under his or her last
will, or by his or her personal representative or
distributee, but only to the extent of the number of shares
purchasable by such Participant pursuant to the provisions
of Section 6(d) at the date of termination of services.

     In the event of the termination of the services of the
holder of an option, other than by reason of Retirement,
disability or death, he or she may (unless the option shall
have been previously terminated pursuant to the provisions
of this Section 6(c) or unless otherwise provided in the
option grant) exercise the option at any time within one
year after such termination but not after the expiration of
the option, to the extent of the number of shares covered by
the option which were purchasable by him or her at the date
of the termination of services, and such option shall
automatically terminate upon the date of such termination of
services for all shares which were not purchasable upon such
date.

     (d)  Notwithstanding the foregoing provisions, the
Committee may determine, in its sole discretion, in the case
of any termination of services, that the holder of an option
may exercise such option to the extent of some or all of the
remaining shares covered thereby whether or not such shares
had become purchasable by such an individual at the date of
the termination of his services and may exercise such option
at any time prior to the expiration of the original term of
the option.  Options granted under the Plan shall not be
affected by any change of relationship with the Corporation
so long as the holder continues to be an employee of the
Corporation or of a subsidiary; however, a change in a
Participant's status from an employee to a nonemployee shall
result in the termination of an outstanding option held by
such Participant in accordance with Section 6(c).  The
Committee, in its absolute discretion, may determine all
questions of whether particular leaves of absence constitute
a termination of service.  Nothing in the Plan or in any
option granted pursuant to the Plan shall confer on any
individual any right to continue in the employ or other
service of the Corporation or any other person or interfere
in any way with the right of the Corporation or any other
person to terminate his or her employment or other services
at any time.

                              10
<PAGE>

     (e)  The date of grant of an option pursuant to the
Plan shall be the date specified by the Committee, or the
Grant Committee acting pursuant to authority granted under
Section 3(b), at the time it grants such option, provided
that such date shall not be prior to the date of such action
by the Committee or the grant Committee, and that the price
shall be determined in accordance with Section 6(a) on such
date.  The Committee or Grant Committee shall promptly
notify a grantee of an award and a written option grant
shall promptly be duly executed and delivered by or on
behalf of the Corporation.

     (f)  The Committee shall be authorized, in its absolute
discretion, to permit option holders to surrender
outstanding options in exchange for the grant of new options
or to require option holders to surrender outstanding
options as a condition precedent to the grant of new
options.  The number of shares covered by the new options,
the option price (subject to the provisions of Section
6(a)), the option period and other terms and conditions of
the new options shall all be determined in accordance with
the Plan and may be different from the provisions of the
surrendered options.

     (g)  Notwithstanding any contrary waiting period,
installment period or other limitation or restriction in any
option agreement or in the Plan, in the event of a Change of
Control, each option outstanding under the Plan shall
thereupon become exercisable at any time during the
remaining term of the option, but not after the term of the
option, to the extent of the number of shares covered by the
option, whether or not such shares had become purchasable by
the Participant thereunder immediately prior to such Change
of Control.

     (h)  Anything in the Plan to the contrary
notwithstanding, during the 90 calendar days from and after
a Change of Control (x) an optionee (other than an optionee
who initiated a Change of Control in a capacity other than
as an officer or a Director of the Corporation) who is an
officer or a Director of the Corporation (within the meaning
of Section 16 of the Exchange Act and the rules and
regulations promulgated thereunder) with respect to an
option that was granted at least six months prior to the
date of exercise pursuant to this sentence and (y) any other
optionee who is not an officer or a Director with respect to
an option shall, unless the Committee shall determine
otherwise at the time of grant, have the right, in lieu of
the payment of the full purchase price of the shares of
Common Stock being purchased under the option and by giving

                          11
<PAGE>

written notice to the Corporation, to elect (within such 90-
day period) to surrender all or part of the option to the
Corporation and to receive in cash an amount equal to the
amount by which the Fair Market Value of the Common Stock on
the date of exercise shall exceed the purchase price per
share under the option multiplied by the number of shares of
Common Stock granted under the stock option as to which the
right granted by this sentence shall have been exercised.
Such written notice shall specify the optionee's election to
purchase shares granted under the option or to receive the
cash payment referred to in the immediately preceding
sentence.

     (i)  Anything in this paragraph 6 to the contrary
notwithstanding, if a stock option of a recipient under an
ATL stock option plan expires, and the expired stock option
at the time of its expiration had value and was for the
purchase of shares of the same class as shares available for
grant under this Plan, and the recipient is eligible for
awards under this Plan as specified in paragraph 5 hereof,
and the Committee feels in its discretion that it is
appropriate or equitable to do so, the Committee may award
such recipient a new stock option under this Plan, for up to
the number of shares of the expired option, such new stock
option to vest immediately upon grant and to expire within a
period of time not greater than 90 day from the date of
grant.

7.  Withholding Taxes

     In connection with the transfer of shares of Common
Stock as a result of the exercise of an option the
Corporation (a) shall not issue a certificate for such
shares until it has received payment from the Participant of
any Withholding Tax in cash or by the retention by the
Corporation or acceptance by the Corporation upon delivery
thereof by the Participant of shares of Common Stock
sufficient in Fair Market Value to cover the amount of such
Withholding Tax and (b) shall have the right to retain or
sell without notice, or to demand surrender of, shares of
Common Stock in value sufficient to cover any Withholding
Tax.  The Corporation shall have the right to withhold from
any cash amounts due from the Corporation to the Participant
pursuant to the Plan an amount equal to the Withholding Tax.
In either case, the Corporation shall make payment (or
reimburse itself for payment made) to the appropriate taxing
authority of an amount in cash equal to the amount of such
Withholding Tax, remitting any balance to the Participant.
For purposes of this Section 7, the value of shares of
Common Stock so retained or surrendered shall be equal to

                         12
<PAGE>

the Fair Market Value of such shares on the date that the
amount of the Withholding Tax is to be determined (the "Tax
Date"), and the value of shares of Common Stock so sold
shall be the actual net sale price per share (after
deduction of commissions) received by the Corporation.

     Notwithstanding the foregoing, the Participant may
elect, subject to approval by the Committee, to satisfy the
obligation to pay any Withholding Tax, in whole or in part,
by providing the Corporation with funds sufficient to enable
the Corporation to pay such Withholding Tax or by having the
Corporation retain or accept upon delivery thereof by the
Participant shares of Common Stock sufficient in Fair Market
Value to cover the amount of such Withholding Tax.  Each
election by a Participant to have shares retained or to
deliver shares for this purpose shall be subject to the
following restrictions:  (i) the election must be in writing
and made on or prior to the Tax Date and (ii) if the
Participant is subject to Section 16 of the Exchange Act, an
election to have shares retained to satisfy the Withholding
Tax must be an irrevocable election made at least six months
prior to the Tax Date or the withholding election must
become effective during the 10-business-day period beginning
on the third business day following the date on which the
Corporation releases for publication its annual or quarterly
summary statements of sales and earnings and ending on the
twelfth business day following the date of release thereof.

8.  Transferability and Ownership Rights of Options

     No option awarded under the Plan shall be transferable
otherwise than pursuant to the designation of a Designated
Beneficiary or by will, descent or distribution, and an
option may be exercised, during the lifetime of the holder
thereof, only by him or her.  The holder of an option shall
have none of the rights of a stockholder until the shares
subject thereto shall have been registered in the name of
such holder on the transfer books of the Corporation.

9.  Section 16(b) Compliance and Bifurcation of Plan

     It is the intention of the Corporation that, if any of
the Corporation's equity securities are registered pursuant
to Section 12(b) or 12(g) of the Exchange Act, the Plan
shall comply in all respects with Rule 16b-3 under the
Exchange Act and, if any Plan provision is later found not
to be in compliance with such Section, the provision shall
be deemed null and void, and in all events the plan shall be
construed in favor of its meeting the requirements of Rule
16b-3.  Notwithstanding anything in the Plan to the

                          13
<PAGE>

contrary, the Board, in its absolute discretion, may
bifurcate the Plan so as to restrict, limit or condition the
use of any provision of the Plan to participants who are
officers and directors subject to Section 16 of the Exchange
Act without so restricting, limiting or conditioning the
Plan with respect to other participants.

10.  Adjustments Upon Changes in Capitalization

     Except as otherwise provided in Section 6(h) and
Section 6(i), in the event of any changes in the outstanding
stock of the Corporation by reason of stock dividends, stock
splits, recapitalizations, mergers, consolidations,
combinations or exchanges of shares, split-ups, split-offs,
spin-offs, liquidations or other similar changes in
capitalization, or any distribution to stockholders other
than cash dividends, the Committee shall make such
adjustments, if any, in light of the change or distribution
as the Committee in its sole discretion shall determine to
be appropriate, in the number and class of shares or rights
subject to options and the exercise prices of the options
covered thereby.  In the event of any such change in the
outstanding Common Stock of the Corporation, the aggregate
number and class of shares available under the Plan and the
maximum number of shares as to which options may be granted
shall be appropriately adjusted by the Committee.

11.  Amendment and Termination

     Unless the Plan shall theretofore have been terminated
as hereinafter provided, the Plan shall terminate on, and no
awards of options shall be made after, October 31, 2002;
provided, however, that such termination shall have no
effect on awards of options made prior thereto.  The Plan
may be terminated, modified or amended by the stockholders
of the Corporation.  The Board of Directors of the
Corporation may also terminate the Plan, or modify or amend
the Plan in such respects as it shall deem advisable in
order to conform to any change in any law or regulation
applicable thereto, or in other respects.  The amendment or
termination of the Plan shall not, without the consent of
the recipient of any award under the Plan, alter or impair
any rights or obligations under any award theretofore
granted under the Plan.

12.  Effectiveness of the Plan

     The Plan shall become effective on November 1, 1992.
The Committee may in its discretion authorize the granting
of options, the exercise of which shall be expressly subject

                          14
<PAGE>

to the conditions that (a) the shares of Common Stock
reserved for issuance under the Plan shall have been duly
listed, upon official notice of issuance, upon each stock
exchange in the United States upon which the Common Stock is
traded and (b) a registration statement under the Securities
Act of 1933, as amended, with respect to such shares shall
have become effective.

                          15




                                                       Exhibit 10.2

                                                       MAY 7, 1997



              ADVANCED TECHNOLOGY LABORATORIES, INC.
                                 
                   Employee Stock Purchase Plan
                                 


1. Definitions

   ''Code'' means the Internal Revenue Code of 1986, as amended or
succeeded by later legislative enactments.

   ''Committee'' means the Committee provided for  in  Section  4,
which shall administer this ESPP.

   ''Common Stock'' means common stock, par value $0.01 per share,
of the Company.

   ''Company''  means  Advanced Technology Laboratories,  Inc.,  a
Washington corporation.

   ''Compensation''  means a Participant's base  salary  plus  any
commissions paid.

   ''ESPP''  means  this  Advanced Technology  Laboratories,  Inc.
Employee Stock Purchase Plan.

   ''Fair  Market Value'' of the Common Stock as of any day  means
the closing price (rounded to the next highest cent in the case of
fractions of a cent) of the Common Stock as reported on  such  day
or,  if  such day is not a trading day of the Nasdaq Stock Market,
the  immediately preceding trading day as reported by  the  Nasdaq
Stock  Market. The Committee, in its sole discretion,  shall  make
all determinations required by this definition.

   ''Participant''  means an employee of ATL Ultrasound,  Inc.,  a
wholly  owned  subsidiary of the Company,  and  its  wholly  owned
subsidiary,  ATL  International, Inc., without  reference  to  any
other  subsidiary or affiliate organization of either corporation,
who is regularly scheduled to work a minimum of 20 hours per week.

   ''Purchase  Period''  means a six month  period  commencing  on
January 1 or July 1.

2. Purpose

   The purpose of this ESPP is to enable Participants to acquire a
larger  personal  proprietary interest  in  the  Company,  and  to
encourage Participants to remain in the employ of the Company  and
have  a personal interest in the success of the Company. This ESPP
is  intended to constitute an ''employee stock purchase plan''  as
defined in the Code, and shall be interpreted and administered  to
further that intent.

  This ESPP is intended to provide Common Stock for investment and
not  for resale. The Company does not, however, intend to restrict
or   influence  the  conduct  of  any  Participant's  affairs.   A
Participant,  therefore, may sell Common Stock that  is  purchased
under  this  ESPP  at  any time, subject to  compliance  with  any
applicable federal or state tax and securities laws. THE  EMPLOYEE
ASSUMES  THE RISK OF ANY MARKET FLUCTUATIONS IN THE PRICE  OF  THE
SHARES.

3. Governmental Regulations

   The  Company's obligation to sell and deliver shares of  Common
Stock  under  this  ESPP  is  subject  to  the  approval  of   any
governmental   authority   required   in   connection   with   the
authorization,  issuance  or sale of such  shares,  including  the
Securities  and Exchange Commission, the securities administrators
of  the  states  in  which Participants reside, and  the  Internal
Revenue Service.

                                 1
<PAGE>


4. Administration

  This ESPP shall be administered by the Compensation Committee of
the  Board of Directors of the Company. The Compensation Committee
shall have plenary authority, in its discretion, to interpret  the
ESPP,  to  prescribe,  amend  and rescind  rules  and  regulations
relating to it, and to make all other determinations necessary  or
advisable  for  the  administration of the ESPP.  The  Committee's
determinations of the matters referred to in this Section 4  shall
be  conclusive.  It  is  the intention  of  the  Company  and  the
Committee  that this ESPP and the administration hereof comply  in
all respects with Section 16(b) of the Securities Exchange Act  of
1934 and Section 423(b) of the Code.

5. Stock Subject to the ESPP

   There  are reserved for issuance under this ESPP 300,000 shares
of Common Stock which may be purchased by Participants pursuant to
this ESPP, subject to adjustment as provided in Section 15.

6. Purchase Periods

   This  ESPP  will be administered based on semi-annual  Purchase
Periods commencing January 1 or July 1. The first Purchase  Period
will begin on January 1, 1997 and end on June 30, 1997.

7. Payroll Deductions.

   Any  person  who is properly enrolled as a Participant  at  the
beginning  of  a  Purchase Period may elect,  in  accordance  with
procedures prescribed by the Committee, to have the Company deduct
a   specified  integer  number  percentage  of  the  Participant's
Compensation  for the purchase of shares of Common Stock  pursuant
to the ESPP.

   The maximum rate of deduction that a Participant may elect  for
any  Purchase  Period  is  15%. An amount  equal  to  the  elected
percentage of the Participant's Compensation shall be deducted  on
each  regular  pay  day  falling within the Purchase  Period.  All
amounts will be deducted from a Participant's Compensation  on  an
after-tax  basis.  No interest will be paid on payroll  deductions
accumulated under this ESPP.

   A  Participant who is enrolled in this ESPP at  the  end  of  a
Purchase Period will, unless the Participant gives notice  of  his
or her intent to withdraw from the ESPP, automatically be enrolled
as a Participant in the subsequent Purchase Period.

8. Purchase of Common Stock

  On the first business day following the end of a Purchase Period
(the  ''Purchase  Date''),  a  Participant's  accumulated  payroll
deductions will, subject to the limitations of Section 9  and  the
termination  provisions  of  Section 14,  be  applied  toward  the
purchase  of shares of Common Stock at a purchase price  equal  to
the lesser of:

     (a) 85% of the Fair Market Value for the Common Stock on  the
  first day of the Purchase Period; or
  
     (b) 85% of the Fair Market Value for the Common Stock on  the
  Purchase Date,
  
in either event rounded to the nearest whole cent.

  Shares of Common Stock may be purchased under the ESPP only with
a  Participant's accumulated payroll deductions. Fractional shares
cannot  be  purchased. At the conclusion of each Purchase  Period,
the  Company shall automatically re-enroll each Participant in the
next   Purchase   Period,  and  any  portion  of  a  Participant's
accumulated payroll deductions not used for the purchase of Common
Stock  at  the  end of a Purchase Period shall be applied  to  the
purchase  of  Common  Stock in the next  Purchase  Period  if  the
Participant  is  participating in the ESPP  during  that  Purchase
Period, or returned to the Participant.

                                 2
<PAGE>


9. Limitations on Share Purchases

   During  any  Purchase Period the maximum number  of  shares  of
Common Stock that may be purchased by a Participant may not exceed
1,000  shares. During any calendar year, the maximum value of  the
Common  Stock  that may be purchased by a Participant  under  this
ESPP  is $25,000, said value to be determined on the basis of  the
Fair  Market  Value of the Common Stock on the first  day  of  the
Purchase  Period and in accordance with the requirements  of  Code
Section  423(b)(8). The foregoing limitation is  intended  to  and
shall  be interpreted in such a manner as will comply with Section
423(b)(8)  of  the  Code.  In addition, no  Participant  shall  be
permitted  to  subscribe for any shares under this  ESPP  if  such
Participant, immediately after such subscription, owns shares that
account  for  (including all shares that may  be  purchased  under
outstanding subscriptions under the ESPP and any other outstanding
options  to purchase shares of Common Stock) five percent or  more
of  the  total  combined voting power or value of all  classes  of
shares  of  the  Company or its subsidiaries.  For  the  foregoing
purposes  the rules of Section 424(d) of the Code shall  apply  in
determining share ownership.

10. Withdrawal from the ESPP

   At any time prior to the last three weeks of a Purchase Period,
a  Participant may elect, in accordance with procedures prescribed
by  the  Committee, to withdraw from the ESPP.  If  a  Participant
withdraws  from  the  ESPP,  all  of  the  Participant's   payroll
deductions  for that Purchase Period will be promptly returned  to
the  Participant,  and the Participant will  not  be  eligible  to
participate in the ESPP again before the next Purchase Period.  If
a  Participant withdraws effective for a Purchase Period that  has
not yet commenced, the Participant may elect to participate in any
subsequent  Purchase Period. If a Participant's payroll deductions
are  interrupted  by  any legal process, the Participant  will  be
deemed  to have elected to withdraw from the ESPP for the Purchase
Period in which the interruption occurs.

   A  Participant's participation and payroll deductions  continue
during  a leave of absence unless the Participant elects  to  stop
his  or  her  payroll  deductions.  Such  participation  will  end
automatically  at  the  end  of the  current  Purchase  Period.  A
Participant  may  re-enroll to participate in subsequent  Purchase
Periods  which commence following the employee's return  from  the
leave of absence.

11. Issuance of Common Stock to Custodial Accounts

   The  shares of Common Stock purchased by Participants  will  be
issued  electronically  by  the  Company's  transfer  agent  to  a
Participant's custodial account as soon as practicable after  each
Purchase  Date.  Common Stock purchased under  the  ESPP  will  be
issued  only  in the name of the Participant (or, if  his  or  her
authorization  so designates, in the name of the  Participant  and
another  person  of  legal age as joint  tenants  with  rights  of
survivorship).  The  custodial account of  Participants  shall  be
maintained by a bank, broker-dealer or similar custodian that  has
agreed  to  hold  such shares for the accounts of  the  respective
Participants.  Fees  and  expenses of the bank,  broker-dealer  or
similar custodian shall be paid by the Company or allocated  among
the  respective  Participants  in such  manner  as  the  Committee
determines.  A Participant or his or her legal representative  may
withdraw  Common Stock from his or her custodial  account  at  any
time;  however any withdrawal within 2 years of the first  day  of
the  Purchase  Period and one year of the Purchase  Date  will  be
treated  by the Company as a disqualifying disposition  under  the
Code and be reported on the Participant's tax Form W-2.

12. Withholding Taxes

   In connection with the purchase of shares of Common Stock under
this  ESPP, the Company (a) shall not issue a certificate for such
shares  until it has received payment from the Participant of  any
required withholding tax in cash or by the retention or acceptance
upon delivery thereof by the Participant of shares of Common Stock
sufficient  in  Fair  Market Value to cover  the  amount  of  such
withholding  tax and (b) shall have the right to  retain  or  sell
without notice, or to demand surrender of, shares of Common  Stock
in  value  sufficient to cover any withholding  tax.  The  Company
shall have the right to withhold from any payroll deductions  made
by the Participant under this ESPP an amount equal to any required
withholding  tax. In either case, the Company shall  make  payment
(or  reimburse itself for payment made) to the appropriate  taxing
authority  of  an  amount in cash equal  to  the  amount  of  such
withholding tax, remitting

                             3
<PAGE>

any  balance to the Participant. For purposes of this Section  12,
the  value  of  shares of Common Stock so retained or  surrendered
shall be equal to the Fair Market Value of such shares on the date
that  the  amount of the withholding tax is to be determined  (the
''Tax  Date''), and the value of shares of Common  Stock  so  sold
shall  be the actual net sale price per share (after deduction  of
commissions) received by the Company.

   Notwithstanding  the  foregoing,  the  Participant  may  elect,
subject to approval by the Committee, to satisfy the obligation to
pay  any  withholding tax, in whole or in part, by  providing  the
Company  with funds sufficient to enable the Company to  pay  such
withholding  tax or by having the Company retain  or  accept  upon
delivery  thereof  by  the  Participant  shares  of  Common  Stock
sufficient  in  Fair  Market Value to cover  the  amount  of  such
withholding  tax. Each election by a Participant  to  have  shares
retained or to deliver shares for this purpose must be in  writing
and made on or prior to the Tax Date.

13. Transferability

   A  Participant's  rights under this ESPP, including  rights  to
accumulated  payroll  deductions, may not  be  pledged,  assigned,
encumbered or otherwise transferred for any reason other  than  by
will  or  the  laws of descent and distribution. Any such  attempt
will be treated as an election by the Participant to withdraw from
this ESPP.

14. Terminating Events

   Upon  (a) the dissolution or liquidation of the Company, (b)  a
merger  or  other reorganization of the Company with one  or  more
corporations  as  a  result of which the Company  will  not  be  a
surviving corporation, (c) the sale of all or substantially all of
the  assets of the Company or a material division of the  Company,
(d)  a  sale  or  other transfer, pursuant to a  tender  offer  or
otherwise,  of  more  than  fifty  percent  (50%)  of   the   then
outstanding  shares  of  Common  Stock  of  the  Company,  (e)  an
acquisition by the Company resulting in an extraordinary expansion
of  the Company's business or the addition of a material new  line
of  business, or (f) any exchange that is subject to this  Section
14  in  accordance with the provisions of Article 15 (any of  such
events  is  herein  referred to as a ''Terminating  Event''),  the
Committee may but shall not be required to:

     (a)  make provision for the continuation of the Participants'
  rights  under  this  ESPP on such terms and  conditions  as  the
  Committee  determines to be appropriate and equitable, including
  where  applicable,  but not limited to, an arrangement  for  the
  substitution  on  an equitable basis, for each share  of  Common
  Stock  that  could  otherwise be purchased at  the  end  of  the
  Purchase  Period  in  progress at the time  of  the  Terminating
  Event,  of  any consideration payable with respect to each  then
  outstanding  share  of  Common  Stock  in  connection  with  the
  Terminating Event; or
  
     (b)  terminate all rights of Participants under the ESPP  for
  such Payment Period and 
  
        (i)  return  to  the  Participants all  of  their  payroll
     deductions for such Payment Period; and
     
        (ii)  for  each share of Common Stock, if any, that  could
     otherwise be purchased under the ESPP by a Participant at the
     end  of  such  Purchase Period (determined by  assuming  that
     payroll  deductions  at the rate elected by  the  Participant
     were continued to the end of the Purchase Period and used  to
     purchase shares based on the Fair Market Value of the  Common
     Stock  on  the  first day of the Purchase  Period)  and  with
     respect  to which (A) the purchase price at which such  share
     could  be  purchased (determined with reference only  to  the
     Fair Market Value of the Common Stock on the first day of the
     Purchase Period) is exceeded by (B) the Fair Market Value  on
     the date of the Terminating Event of a share of Common Stock,
     as  determined  by the Committee, pay to the  Participant  an
     amount equal to such excess.
     
   The  Committee  shall  make  all  determinations  necessary  or
advisable   in  connection  with  Terminating  Events,   and   its
determinations  shall, in the absence of fraud or patent  mistake,
be  conclusive and binding on all persons with any interest in the
ESPP.

                                4
<PAGE>


15. Adjustments Upon Changes in Capitalization

   In  the  event of any changes in the outstanding stock  of  the
Company    by   reason   of   stock   dividends,   stock   splits,
recapitalizations,   mergers,  consolidations,   combinations   or
exchanges    of   shares,   split-ups,   split-offs,    spin-offs,
liquidations  or other similar changes in capitalization,  or  any
distribution  to  stockholders  other  than  cash  dividends,  the
Committee  shall make such adjustments, if any, in  light  of  the
change  or  distribution as the Committee in its  sole  discretion
shall  determine  to  be appropriate in the number  and  class  of
shares  and the purchase prices of the Common Stock which  may  be
purchased  by Participants during the current Purchase Period.  In
the  event of any such change in the outstanding Common  Stock  of
the  Company,  the aggregate number and class of shares  available
under  this  ESPP and the maximum number of shares  which  may  be
purchased and their purchase price shall be appropriately adjusted
by the Committee.

  Upon the happening of an event specified in this Section 15, the
class and aggregate number of shares available under this ESPP, as
set  forth in Section 5 shall be appropriately adjusted to reflect
the  event. Notwithstanding the foregoing, such adjustments  shall
be  made only to the extent that the Committee, based on advice of
counsel for the Company, determines that such adjustments will not
constitute a change requiring shareholder approval under 423(b)(2)
of the Code.

16. Termination of Employee's Rights

  Subject to the provisions of the next paragraph, a Participant's
rights  under this ESPP will terminate if he or she for any reason
(including   death,   disability  or  voluntary   or   involuntary
termination of employment) ceases to be an employee of the Company
or  one  of its subsidiaries. To the extent that the rights  of  a
Participant terminate in accordance with this Section 16,  any  of
the  Participant's  accrued payroll deductions  will  be  promptly
returned to the Participant or his or her personal representative.

  This ESPP does not, directly or indirectly, create any right for
the   benefit   of   any  employee  or  class  of   employees   to
preferentially purchase any Common Stock under the ESPP, or create
in  any  employee or class of employees any right with respect  to
continuation  of employment by the Company, and it  shall  not  be
deemed  to  interfere  in  any way with  the  Company's  right  to
terminate,  or otherwise modify, an employee's employment  at  any
time.

17. Termination and Amendments to ESPP

   This  ESPP may be terminated at any time by the Committee  but,
except  as  provided  in  Section 14, such termination  shall  not
affect  the rights of Participants under the ESPP for the Purchase
Period  in  progress at the time of termination.  This  ESPP  will
terminate  in  any  case  when all or  substantially  all  of  the
unissued shares of Common Stock reserved for the purposes  of  the
ESPP  have  been purchased. If at any time shares of Common  Stock
reserved for the purpose of the ESPP remain available for purchase
but not in sufficient number to satisfy all then unfilled purchase
requirements,  the  available shares shall  be  apportioned  among
Participants  in  proportion to the respective  amounts  of  their
accumulated payroll deductions, and the ESPP shall terminate. Upon
such termination or any other termination of the ESPP, all payroll
deductions  not used to purchase shares of Common  Stock  will  be
refunded to the Participants entitled thereto.

   This  ESPP  may  be  terminated, modified  or  amended  by  the
shareholders of the Company. The Board of Directors of the Company
may  also terminate this ESPP, or modify or amend the ESPP in such
respects  as  it shall deem advisable in order to conform  to  any
change  in any law or regulation applicable thereto, or  in  other
respects;  however, to the extent required by  applicable  law  or
regulation,  shareholder  approval  will  be  required   for   any
amendment which will (a) increase the total number of shares which
may  be  issued  under the ESPP, (b) change the class  of  persons
eligible  to purchase Common Stock under the ESPP, (c)  materially
increase the benefits accruing to Participants under the ESPP,  or
(d)  otherwise  require shareholder approval under any  applicable
law or regulation.

                                   5
<PAGE>

18. Information to Participants

   A  Participant  in this ESPP shall not have  any  rights  as  a
shareholder  of the Company on account of shares of  Common  Stock
that may be purchased under the ESPP prior to the time such shares
are   actually   purchased  by  and  issued  to  the  Participant.
Notwithstanding the foregoing, the Company shall deliver  to  each
Participant  under this ESPP who does not otherwise  receive  such
materials (a) a copy of the Company's annual financial statements,
together  with management's discussion and analysis  of  financial
condition and results of operations for the fiscal year, and (b) a
copy  of  all  reports, proxy statements and other  communications
distributed to the Company's security holders generally.

19. Approval of Shareholders

   This  ESPP  shall  be  effective January 1,  1997,  subject  to
approval by the holders of a majority of the shares of the Company
present or represented by proxy at the first annual meeting of the
shareholders of the Company held after the date on which the  ESPP
is  adopted by the Board of the Company. This ESPP shall  also  be
subject to approval by the shareholders of the Company in a manner
that  complies  with  Section  423(b)(2)  of  the  Code.  If  such
approvals  do  not  occur prior to the end of the  first  Purchase
Period  under  the ESPP, this ESPP and all rights of  Participants
under  the  ESPP  shall terminate, and all payroll  deductions  of
Participants accumulated under the ESPP will be promptly  returned
to the Participants.


Approved by Shareholders on May 7, 1997

                                   6



                                                 
KPMG Peat Marwick Letterhead
                                                        Exhibit 23.1


                   CONSENT OF INDEPENDENT
                CERTIFIED PUBLIC ACCOUNTANTS
        ------------------------------------------------

The Board of Directors
Advanced Technology Laboratories, Inc.:

We consent to the use of our reports incorporated herein by
reference in the registration statement.

KPMG Peat Marwick LLP


Seattle, Washington
June 24, 1997




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission